Harlow, United Kingdom

Gary Christie


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:

goldMedal3 out of 832,680 
Other
 patents

Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Gary Christie: Pioneering Research in Human Health

Introduction: Gary Christie is an outstanding inventor based in Harlow, GB, known for his significant contributions to the field of biomedicine. With a total of three patents to his name, Christie is focused on groundbreaking research that holds promise for treating critical human diseases such as Alzheimer's and cancer. His inventive work demonstrates a commitment to improving health outcomes through innovative therapies.

Latest Patents: Gary Christie's most recent patents include developments in mouse aspartic secretase proteins. His patent on Mouse Aspartic Secretase-2 (mASP-2) describes polypeptides and polynucleotides, as well as methods for producing such polypeptides using recombinant techniques. Additionally, the patent outlines methods for screening compounds that can either agonize or antagonize mASP-2, suggesting potential applications in treating Alzheimer’s disease, cancer, and prohormone processing. Furthermore, his patent on Mouse Aspartic Secretase-1 (mASP1) similarly addresses polypeptides and polynucleotides, alongside methods for producing these proteins through recombinant techniques and screening for related compounds.

Career Highlights: Throughout his career, Gary Christie has made notable advancements in the understanding of aspartic secretases, which are critical in various biological processes and disease mechanisms. His relentless pursuit of knowledge and innovation has positioned him as a prominent figure within biomedicine, emphasizing the importance of patenting intellectual property to safeguard and promote scientific discoveries.

Collaborations: Collaboration plays a crucial role in Christie's research endeavors. He has worked alongside talented colleagues, including Xiaotong Li and David J. Powell. These partnerships have fostered an environment of innovation, facilitating a collaborative approach to address complex challenges in human health.

Conclusion: Gary Christie is an exemplary inventor whose work continues to impact the field of biomedicine. His patents on mouse aspartic secretases represent just a fraction of his contributions, with potential implications for treating serious diseases. Through collaboration and innovation, Christie stands as a pivotal figure driving advancements in health-related research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…